The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1107
ISSUE 1107
June 25, 2001
Issue 1107
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Galantamine (Reminyl) for Alzheimer's Disease
June 25, 2001 (Issue: 1107)
Galantamine hydrobromide (Reminyl), a tertiary alkaloid and phenanthrene derivative extracted from daffodil bulbs, is now being marketed for oral treatment of mild to moderate Alzheimer's disease. Galantamine is the fourth acetylcholinesterase...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.